Mirae Asset Global ETFs Holdings
TELO icon

Mirae Asset Global ETFs Holdings’s Telomir Pharmaceuticals TELO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,167
Closed -$36.1K – 3280
2025
Q1 		$36.1K Buy
11,167
+468
+4% +$2.04K ﹤0.01% 2901
2024
Q4 		$44.1K Buy
10,699
+7,879
+279% +$37.1K ﹤0.01% 2925
2024
Q3 		$18.1K Buy
+2,820
New +$13.7K ﹤0.01% 3020

Other funds holding TELO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TELO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Telomir Pharmaceuticals (TELO) in Q2 2025, closing a stake of 11,167 shares — an estimated $36.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in TELO in Q3 2024 and held it in 3 quarters. The position peaked at $44.1K in Q4 2024. 43 funds tracked by Wall St. Rank hold TELO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Telomir Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 11,167 Telomir Pharmaceuticals shares in Q2 2025, an estimated $36.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Telomir Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Telomir Pharmaceuticals position peaked at $44.1K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.